logo
Northland's Meth Crisis: ‘There's No Magic Wand For Any Of This'

Northland's Meth Crisis: ‘There's No Magic Wand For Any Of This'

Scoop05-05-2025

Article – RNZ
Organisations trying to help people get off meth in Northland towns like Kaikohe say they are overwhelmed by 'a tsunami of need'.
More funding – and residential care for addicts trying to quit – is desperately needed to tackle the problem, they say.
Wastewater testing has shown methamphetamine use tripled in Northland last year, which now has the unenviable title of meth capital of New Zealand.
Tia Ashby heads Te Hau Ora o Ngāpuhi, a Kaikohe-based iwi organisation that provides housing, health services and programmes like Paiheretia, which helps men caught up in the Corrections system.
She said the meth crisis was 'real, complex and growing'.
'We see the daily toll it takes on whānau, on their wairua, their homes and their hope. We do what we can, but the reality is, the demand is outpacing our capacity,' she said.
'We're just not funded at the scale needed to respond to the tsunami of need we are facing.'
Jade and Scott – they did not want to give their last names, because their work brings them into contact with organised crime – are employed by Te Hau Ora o Ngāpuhi as kaiarataki, or navigators, helping meth addicts and their whānau get the help they need.
Jade said the problem was getting worse, and the money spent on drugs meant other family members missed out on essentials.
'The biggest thing that we see is the effect on the kids, on the mokos. You've got whānau that are going without kai, the living conditions can be appalling. It's a real pandemic, you could call it, and has some real atrocious effects.'
Scott said the men they helped came with a whole raft of problems, including homelessness, poor health, mental distress, and crime.
But when they burrowed deeper, they often found the underlying cause was meth.
Scott said there were many reasons behind the drug's prevalence.
'Obviously, the cost of living out there. High unemployment. And people's trauma as well. It's about unpacking it all to find out why people are addicted to methamphetamine. It ruins households, it ruins families, it ruins communities, it brings crime. Nothing will ever end good unless people stop taking it.'
Ashby said the government's Resilience to Organised Crime in Communities ROCC programme, which had so far been rolled out in seven regions across New Zealand, was a good start.
Although still in its early stages, ROCC aimed to stop people becoming addicted in the first place.
'It will build up resilience within whānau and prevent rangatahi [youth] from ever wanting to pick up the pipe, by making sure they're on the right pathway for education or employment, and not being led by gangs,' Ashby said.
'The focus needs to be upstream, we don't want to be the ambulance at the bottom of the cliff all the time. But the reality is, those who have addiction need support now. There's no magic wand for any of this.'
While ROCC was 'a step in the right direction', more and sustainable investment in prevention was needed.
Also desperately needed was comprehensive, culturally responsive residential treatment in mid-Northland for people who wanted to come off drugs.
Currently most providers of those services, such as Grace Foundation and Higher Ground, were based in Auckland.
Ashby said everyone would have to work together to tackle the meth conundrum.
Police, MSD, iwi, Māori providers and local services such as Whakaoranga Whānau Recovery Hub were doing their best with the resources they had, she said.
'But without the right tools, good intentions can only go so far. It's time to match the scale of the response with the scale of the need.'
While the meth problem was not new, it hit headlines last month when Ngāpuhi chairman Mane Tahere made a public call for more policing and direct funding for iwi organisations whose work was slowed by government red tape.
Northland MP Grant McCallum subsequently met Tahere and Far North Mayor Moko Tepania, who lives in Kaikohe, as well as staff at the local medical centre.
He was shocked by the stories they told him.
They included accounts of a young man high on meth assaulting staff and 'causing mayhem' at the medical clinic, and of drug-induced family dysfunction with girls as young as 11 becoming pregnant.
'But the thing that just got me is, you know how when we were growing up, your dad might give you a sip of his beer or something when you're a young kid? Well, in some families, they're giving him a little bit of P.'
McCallum said he was pleased Tahere and Ngāpuhi were standing up and saying they had had enough.
'We have to try and break this cycle. It won't be fixed in five minutes, but we have to start, and one of the key things we've got to do to help break that cycle is get children to school and keep them there,' McCallum said.
In the longer term, he said the answer lay in a stronger local economy and a good education system, so people in towns like Kaikohe had well-paying jobs and children had options for their future.
'But ultimately – and this applies to any community, we're not picking on Kaikohe here, it's just the first cab off the rank – the community has to own this problem. If they don't want drugs in their community, they need to make it clear they don't want it in their community. And they need to push back and feed information through to the police when they find people dealing.'
During a recent visit to Whangārei, Mental Health Minister Matt Doocey said the government was focussed on trying to stop drugs entering the border, coming down hard on dealers and organised crime, and taking a health-led approach to drug users.
Although wastewater testing had shown a big jump in meth use, other data showed the number of users had not increased significantly.
That suggested the same group of people was taking more meth, he said.
Doocey offered a sliver of hope to organisations like Te Hau Ora o Ngāpuhi, who were calling out for more funding to prevent people becoming addicted in the first place.
'We're looking at the Proceeds of Crime Fund to fund some of that. When you look at some of the high-need areas like Northland, it will be a more targeted response. Also, we'll be looking at how we can resource existing services on the ground, who are already delivering, to scale up to the need,' he said.
The Proceeds of Crime Fund, which reopened recently for applications after a three-year freeze, would now focus on reducing violent crime.
Such crime was often driven by drugs, Doocey said.
Meanwhile, back on the front line, Jade said collective action and more funding were vital.
'I'm not sure that heavy handedness in the justice system, and filling the jails in a system that isn't working for our people anyway, is the right solution,' he said.
'It's going to get worse unless we can get ahead of it, and work together in the same direction. I'm not saying we haven't done that in the past but it's going to need an even more collective approach. And I'm hoping people come with wallets open because it's going to need to be funded.'
Scott highlighted the need for comprehensive residential treatment in Northland, so people didn't need to have to be shipped off to Auckland for help.
'You'll never stop drugs, but we can come together and try to minimise it. What that looks like, I don't know. Police are obviously under the pump out there, like everyone else,' he said.
'I think we need some more healing centres for whānau up here in Kaikohe. I don't like using the word rehabilitation. What's needed is a one-stop shop where people can reside, they can heal, get counselling, work on physical fitness, and the kids can go to school.'

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Despite Being Preventable And Curable Cervical Cancer Remains 4th Biggest Cancer In Women
Despite Being Preventable And Curable Cervical Cancer Remains 4th Biggest Cancer In Women

Scoop

time13 hours ago

  • Scoop

Despite Being Preventable And Curable Cervical Cancer Remains 4th Biggest Cancer In Women

Cervical cancer (cancer of the cervix) is preventable and curable, only if it is detected early and managed effectively. Yet it is the 4th most common cancer among women worldwide, with the disease occurring in 660,000 women and claiming the lives of 350,000 women in 2022 worldwide, as per the World Health Organization (WHO). China, India, and Indonesia had the highest number of cervical cancer cases in 2022. Moreover 42% of cervical cancer cases and 39% of deaths associated with it worldwide, took place in China and India- 23% cases and 16% deaths in China, and 19% cases and 23% deaths in India. India reported over 123,000 new cases of cervical cancer and around 77,000 deaths – highest number of deaths worldwide in 2022. Cervical cancer disproportionately affects younger women, and as a result, 20% of children who lose their mother to cancer do so due to cervical cancer, says WHO. As cervical cancer is the only cancer that can be eliminated, the WHO Director General had called upon the governments in 2018 to eliminate it. All governments globally committed to do so by 2030 (by endorsing the global strategy to eliminate cervical cancer by 2030 at the World Health Assembly 2020). But despite some progress, the world is way off the mark from the elimination goal in 2025. Where cervical cancer burden is greatest, access to lifesaving services is most broken Cervical cancer reflects the global inequities between the Global North and the Global South: The highest rates of cervical cancer incidence and mortality are in low- and middle-income countries. In fact, 94% of the cervical cancer deaths in 2022 took place in these countries where access to health services is appalling. This reflects major health inequities which are driven by lack of access to vaccination, cervical cancer screening and treatment services. Prophylactic vaccination against human papilloma virus (HPV) - which is one of the most common sexually transmitted infections and which causes cervical cancer - and screening, and treatment of pre-cancer lesions are very cost-effective strategies to prevent cervical cancer. WHO's call to deliver on #HealthForAll dates to the 1970s, but even now gaping health inequities and injustices plague the health systems – especially in the Global South. Vaccines against HPV have existed since almost 20 years now. No surprise for guessing that both Cervarix (made by Glaxo) and Gardasil (made by Merck) were made in the rich nations – and their rollout in the Global South has been far from ideal. In 2022, India-based Serum Institute in collaboration with the Department of Biotechnology of the government of India developed India's first indigenously produced HPV vaccine called Cervavac. So, now there is a vaccine developed in the Global South too. But its rollout is far from ideal as of now. It is still not a part of India's public health programme, for instance. Same inequities block access to HPV screening in the Global South "Almost all cervical cancers (~95%) are caused by persistent HPV infection. Women living with HIV are 6 times more likely to develop cervical cancer compared to the general population, and an estimated 5% of all cervical cancer cases are attributable to HIV,' said Dr Kuldeep Singh Sachdeva, former head of Indian government's national TB and HIV programmes. Dr Sachdeva was speaking at the National Dialogue and stakeholder meet organised by National Coalition of People living with HIV in India (NCPI Plus) bringing together over 100 community leaders from almost all states of India. Dr Sachdeva currently leads Molbio Diagnostics as President and Chief Medical Officer. He was speaking ahead of 10th Asia-Pacific AIDS & Co-Infections Conference (APACC 2025), Japan; 2nd Asia Pacific Conference on Point of Care Diagnostics for Infectious Diseases (POC 2025), Thailand; and 13th International AIDS Society Conference on HIV Science (IAS 2025), Rwanda. Cervical cancer screening efforts in most settings of the Global South have long been hampered by reliance on outdated methods like pap smears and visual inspection with acetic acid (VIA) test, both of which suffer from poor sensitivity, high subjectivity, and dependence on specialised infrastructure. Advanced molecular HPV tests developed by the Global North, while highly accurate than pap smear and VIA, remain inaccessible for most women living in peripheral, rural, and resource-limited settings, especially of the Global South. India's first point-of-care HPV test that can be deployed at point-of-need in the Global South In April 2025, India's first ever indigenously developed RT-PCR molecular test for HPV on Truenat (called HPV-HR Plus) got an independent multi-centric validation done by Government of India's Department of Biotechnology, Biotechnology Industry Research Assistance Council (BIRAC) and Grand Challenges India. Truenat HPV-HR Plus test is made by Molbio Diagnostics in India. This independent validation of Truenat HPV-HR Plus was conducted under the study 'Validating Indigenous Human Papilloma Virus (HPV) Tests for Cervical Cancer Screening in India.' The study involved leading Indian government's research institutes, including All India Institute of Medical Sciences (AIIMS) Delhi, ICMR National Institute for Cancer Prevention and Research (NICPR) Noida, and ICMR National Institute for Research in Reproductive and Child Health (NIRRCH) Mumbai, in collaboration with WHO's International Agency for Research on Cancer (IARC). There are over 200 genotypes of HPV but those that put the infected person at risk of developing cervical cancer are few. Truenat HPV-HR Plus molecular test enables detection for 8 HPV high-risk genotypes – which account for over 96% cervical cancer cases worldwide. These HPV high-risk genotypes include 16, 18, 31, 33, 35, 45, 52 and 58. Out of these, 16 and 18 high-risk genotypes dominate globally as 77% of invasive cervical cancer cases are associated with them. These high-risk genotypes can also cause cancer of the anus, penis, vagina, vulva, and oropharynx (throat). Raising cervical cancer awareness and health literacy among people with HIV As women living with HIV are 6 times more at risk of cervical cancer, communities and networks of people with HIV must come forward to find ways to integrate cervical cancer screening as well as for other cancers (such as breast cancer) programmatically and in people-centred manner, said Daxa Patel, co-founder of National Coalition of People living with HIV in India (NCPI Plus) and its former President. Agrees Pooja Mishra, Secretary of NCPI Plus that it is unacceptable when cervical cancer, which is preventable and curable - and the only cancer which can be eliminated - still kills 350,000 women worldwide. We also need to raise awareness, health and treatment literacy among the young people, said Mishra. That is why NCPI Plus took leadership in organising a national dialogue and stakeholder consultation on preventing cancers among people with HIV, especially women. Truenat HPV-HR Plus test is critical for closing the screening gap, particularly for asymptomatic women and women who are at higher risk for persistent HPV infection. By shifting HPV screening closer to the most-at-risk people and communities, this test ensures early detection, better triaging, and timely treatment - especially in historically underserved populations. Over 10,000 Truenat RT-PCR molecular test machines are already deployed globally in over 85 countries (mostly for TB), and mostly in the Global South nations in remote settings. Truenat is a battery operated (with solar power charging), laboratory independent, de-centralised and point-of-care test that provides highly accurate diagnosis for over 30 diseases (including TB, HPV, HCV, HBV, STIs, COVID-19, etc) within an hour – thus enabling same day test and treat, counselling and follow-up. Superiority of Truenat HPV-HR Plus test Older Pap smear test detects precancerous or cancerous cervical cancer cells whereas Truenat HPV-HR Plus test detects the presence of high-risk HPV DNA (8 genotypes). Pap smear is a cytological screening test and depends on the observing medical expert's skill and slide quality, whereas Truenat is a PCR-based nuclear acid amplification test with very high sensitivity and specificity. False negative reports are higher and false positive reports are also moderate when pap smear is used whereas both are low with Truenat HPV-HR Plus. The most recent validation of Truenat HPV-HR Plus showed 100% specificity and 100% sensitivity. Truenat HPV-HR is designed to work with cervical swab samples collected by a clinician (self-collection of samples is still under evaluation), and it gives highly accurate results in just 60 minutes. Whereas, a pap smear results may take 3-7 days as these are laboratory dependent. Easy to use and with high stability at room temperature, Truenat HPV-HR Plus requires minimal biosafety and is optimised for use at both the laboratory and near-patient settings. This test overcomes shortcomings of current diagnostic methods, including variable sensitivity and specificity, high costs, complex workflows, and dependence on advanced equipment, said Dr Sachdeva. Highlighting the importance of developing health technologies in the Global South, Rajesh S Gokhale, Secretary, Department of Biotechnology, Ministry of Science and Technology, Government of India said, 'Truenat HPV-HR Plus represents the kind of diagnostic innovation we need - dependable, scientifically rigorous, locally developed, and built to serve our public health system. It is a huge step forward in strengthening cervical cancer screening across India.' "HPV infection is common. However, persistence of HPV infection could be deadly. Studies show that nearly half of persistent HPV infections do not resolve by 24 months. These silent carriers drive the progression to high-grade pre-cancerous lesions and cancer. That's why extended HPV genotype detection is crucial," shared Dr Sachdeva. HPV also causes oropharyngeal cancers Oropharyngeal cancers related to HPV vary from 28% to 68% in the richer nations. Indian studies also show alarming numbers though, more research is needed for science-informed responses towards eliminating HPV related cancers in our population, said Dr Ishwar Gilada, President Emeritus of AIDS Society of India (ASI) and Governing Council member of International AIDS Society (IAS). 'While there is increasing evidence of HPV-associated oropharyngeal cancer in both men and women globally, there still remain gaps in gender-neutral HPV vaccination policies globally,' said Dr Sachdeva. Community leaders like Manoj Pardeshi, who is among the co-founders and inspiring lights of NCPI Plus, said that regardless of gender, all those eligible and at risk of HPV related cancers, must be vaccinated against HPV. Programme addressing cervical cancer elimination should expand to eliminate all HPV related cancers in people-centred ways, regardless of gender. HPV is transmitted through: - Sexual contact: Transmission mode is through vaginal, anal, or oral sex with an infected person. - Skin-to-skin contact: Transmitted through non-penetrative sexual activities involving skin-to-skin contact. The WHO Guidelines recommend HPV detection via molecular test after age of 30 (and every 5 years thereafter). Vaccination against HPV is highly recommended for younger people under the age of 15 or before the initiation of sexual activity. Do not leave equity behind 'Truenat HPV-HR Plus test is about equity in detection. By expanding beyond traditional targets, we reach the genotypes that matter more in our populations for cervical cancer elimination. This means earlier intervention, fewer missed cases, and better outcomes,' said Dr Sachdeva. Truenat HPV-HR Plus offers the best of both worlds - critical genotype coverage and real-world deploy-ability. What does it mean to eliminate cervical cancer by 2030? To eliminate cervical cancer, all countries must reach and maintain an incidence rate of below 4 per 100,000 women. Achieving that goal rests on three key pillars and their corresponding targets: vaccination: 90% of all eligible young people must be fully vaccinated with the HPV vaccine by the age of 15. screening: 70% of women should be screened using a high-performance test by the age of 35, and again by the age of 45; treatment: 90% of women with pre-cancer treated and 90% of women with invasive cancer managed. No other cancer but cervical cancer is fully preventable and curable if detected and managed early. Even one death from it is a death too many. Shobha Shukla – CNS (Citizen News Service) (Shobha Shukla is the award-winning founding Managing Editor and Executive Director of CNS (Citizen News Service) and is a feminist, health and development justice advocate. She is a former senior Physics faculty of prestigious Loreto Convent College and current Coordinator of Asia Pacific Regional Media Alliance for Health and Development (APCAT Media) and Chairperson of Global AMR Media Alliance (GAMA received AMR One Health Emerging Leaders and Outstanding Talents Award 2024). She also coordinates SHE & Rights initiative (Sexual health with equity & rights). Follow her on Twitter @shobha1shukla or read her writings here

‘HIV Should Not Be A Death Sentence In Fiji' – Call For Testing Amid Outbreak
‘HIV Should Not Be A Death Sentence In Fiji' – Call For Testing Amid Outbreak

Scoop

time2 days ago

  • Scoop

‘HIV Should Not Be A Death Sentence In Fiji' – Call For Testing Amid Outbreak

Article – RNZ There were 490 new HIV cases in Fiji from October – December last year. Fiji's Minister for Health & Medical Services has revealed the latest HIV numbers in the country to a development partner roundtable on the country's response. There were 490 new HIV cases from October – December last year, bringing the 2024 total to 1583. 'Included in this number are 32 newborns diagnosed with HIV acquired through mother-to-child transmission,' Dr Atonio Rabici Lalabalavu said. Fiji declared an outbreak of the disease in January. The Fiji Sun reported around 115 HIV-related deaths in the January-September 2024 period. Fiji's Central Division reported 1100 new cases in 2024, with 427 in the Western Division and 50 in the Northern Division. Of the newly recorded cases, less than half – 770 – have been successfully linked to care, of which 711 have been commenced on antiretroviral therapy (ART). Just over half were aged in their twenties, and 70 percent of cases were male. Dr Lalabalavu said the increase in HIV cases is also seeing an increase in tuberculosis and HIV co-infection, with 160 individuals in a year. He said the ministry strongly encourages individuals to get tested, know their status, and if it is positive, seek treatment. And if it is negative, to maintain that negative status. 'I will reiterate what I have said before to all Fijians – HIV should not be a death sentence in Fiji.' In the Western Pacific, the estimated number of people living with HIV (PLHIV) reached 1.9 million in 2020, up from 1.4 million in 2010. At the time, the World Health Organisation said over the previous two decades, HIV prevalence in the Western Pacific had remained low at 0.1 percent. However, the low prevalence in the general population masked high levels of HIV infection among key populations.

Live: Power cuts, flood threats as storm hits from Northland to Wellington
Live: Power cuts, flood threats as storm hits from Northland to Wellington

RNZ News

time4 days ago

  • RNZ News

Live: Power cuts, flood threats as storm hits from Northland to Wellington

Photo: RNZ/Mark Papalii High tide is imminent for the Tauranga-Taupō River and residents are being warned they may need to evacuate if it breaches its banks. Earlier Strong winds have lifted the roof of a house in the Wellington suburb of Newlands to land on a house on another street. The gales followed a night of heavy rain, thunderstorm warnings and strong winds across much of the country. MetService said the downpours across the North Island and parts of the South Island were giving way to snowfall on Wednesday night. Sign up for Ngā Pitopito Kōrero , a daily newsletter curated by our editors and delivered straight to your inbox every weekday.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store